Zawiadomienie od osoby zobowiązanej.

The Management Board of Organic Farma Zdrowia S.A. filed an ESPI current report indicating that it received a notification from an obligated insider about transactions in the company's shares. The filing includes an attachment with the notification, but the specific transaction details (shares, price, dates) are not disclosed in the text. This is a routine compliance filing under MAR Article 19(3) and does not contain material financial information. Consequently, the market impact is expected to be negligible, and no immediate broker action is required. The filing serves to keep the market informed of potential insider activity, maintaining transparency under KNF regulations. Given the lack of quantitative data, there is no basis to assess the direction or magnitude of any price effect. The filing is typical for NewConnect listed companies and does not signal any change in corporate strategy, financial performance, or governance. Risks remain limited to the possibility of undisclosed insider activity, but without further details, the event is considered routine.